Pure Global AI
NCT06032663Not yet recruiting

Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications

Sheffield Teaching Hospitals NHS Foundation TrustClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Head and Neck Cancer
Drug/Device/Intervention
PET-MRI
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2024
End date
Dec 01, 2024
Enrollment
10 participants
Primary outcome

Completion of PET-MRI

Summary

The primary research question to be answered in this project is Are patients with
 locally-advanced head and neck cancer able to tolerate a PET-MRI scan when they are
 immobilised in a radiotherapy treatment shell? This will be assessed by measuring the
 proportion of patients that complete the full scanning protocol and by obtaining participant
 feedback on their experience of completing the scan.
 
 The secondary question is Can a PET-MRI scan fused with a planning CT scan improve the
 accuracy in radiotherapy planning of patients with head and neck cancer? Accuracy will be
 assessed by:
 
 1. Comparing the radiotherapy target volumes and radiotherapy plans with and without the
 use of a PET-MRI scan.
 
 2. Comparing inter- and intra-observer variability in treatment contours with and without
 the use of a PET-MRI scan within and between oncologists and implications of that.

ICD-10 classifications
Malignant neoplasm of other and ill-defined sites: Head, face and neckMalignant neoplasm: Skin of scalp and neckMalignant neoplasm: Connective and soft tissue of head, face and neckCarcinoma in situ: Skin of scalp and neckSecondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06032663
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06032663 through Pure Global AI's free database. This phase not specified trial is sponsored by Sheffield Teaching Hospitals NHS Foundation Trust and is currently Not yet recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.